From
Until
  • Story
  • 09 January 2018

Despite being a centenary drug, heparin remains as one of the essential drugs of medicine and especially of modern surgery but, in addition, possible applications in malaria, cancer or fertility are being investigated.

  • Story
  • 16 November 2017

The use of heparin in pregnancy is increasingly common to avoid thromboembolic complications, abortions or delays in fetal growth. In this story, Monica tells us how thanks to heparin, she was able to bring her third pregnancy to term.

  • Story
  • 19 October 2017

Since its foundation in 1975, Bioiberica has been focused on the production of heparin. The company understood that it was an active ingredient indispensable for human health and that it was important to be able to offer the maximum guarantees of safety and traceability. Today, one out of every five heparin doses administered worldwide has been developed and manufactured by Bioibérica.

 

  • Story
  • 04 September 2017

Although they may appear immune to thrombosis due to their physical training, athletes are not risk free. In this story we’ll meet Jennifer Pareja, world water polo champion, and how heparin helped her to continue his sports career.

  • Story
  • 03 July 2017

Who discovered Heparin? Was it Jay McLean, the student? Or was it its teacher, William Howell? What is clear is that, 100 years ago, that scientific discovery Made his mark on the history of medicine forever.

  • Story
  • 12 June 2017

The Catalan Institute of Bioengineering, the Barcelona Institute of Global Health and Bioibérica have joined forces to study the development of new compounds derived from heparin to fight malaria, a disease that infects 200 million people each year and causes half a million deaths. 

  • Story
  • 09 May 2017

Professor Hemker has published over 400 research papers on Haemostasis and Thrombosis and has also dedicated his professional life to studying the action of heparin in the treatment of this disease. In this story he shows a more personal side...

  • Story
  • 04 April 2017

It is estimated that one or two women in a thousand may have thrombosis during pregnancy. In fact, gestation increases the risk of thrombosis 3 to 6 times compared to the situation of non-pregnancy. Cristina Domingo had this complication in her eighth month and thanks to heparin could overcome it. This is her story.

  • Story
  • 23 March 2017

Late September 2016, leading glycosaminoglycan specialists convened to discuss the future of Heparin at the Institute Ronzoni Symposium, and we had the opportunity to talk to some of them. At this interview, Mr. Shriver talks about the recent efforts to take molecular level characterization techniques and apply them to the control of heparin.